A Case of Cavernous Lymphangioma in the Lower Part of the Chin that Became Massive During Follow-up
Sunaki Noguchi DDS, PhD, Oral Medicine and Maxillofacial surgery, Tokyo Dental College, Ichikawa, Japan
Teruhide Hoshino , Tokyo Dental College Ichikawa General Hospital, Ichikawa,Chiba, Japan
Yuka Yuzawa , Department of Oral Medicine,Oral and Maxillofacial Surgery, Tokyo Dental College Ichikawa Generel Hospital, Ichikawa,Chiba, Japan
Takehiro Ichijima , Department of Oral Medicine,Oral and Maxillofacial Surgery, Tokyo Dental College Ichikawa General Hospital, Ichikawa,Chiba, Japan
Takeo Shibui , Tokyo Dental College Ichikawa General Hospital, Ichikawa,Chiba, Japan
Akira Katakura DDS, PhD, Department of Oral Medicine,Oral and Maxillofacial Surgery, Tokyo Dental College Ichikawa General Hospital, ,Ichikawa,Chiba, Japan
Lymphangioma is a benign, non-epithelial tumor resulting from proliferation of lymphatic vessels, and as with hemangioma, is said to often be regarded as tissue malformation. While the mainstream view is that lymphangioma is a tumor that is based on a congenital disease caused by a developmental abnormality in the lymphatic system during the embryonic stage. There are many cases in which rapid resection is performed, specifically cases accompanied by bleeding and infection despite a low level of emergency and cases in which rapid enlargement of the tumor is seen. Lymphangioma has a lower incidence than hemangioma, and it commonly occurs in the tongue, lips, and cheeks in the oral region.
While there have been many reports on cases of cystic lymphangioma in multiple organs as well, in addition to investigation of its treatment, reports on neck lesion cavernous lymphangioma are extremely rare. We herein report our experience with a case of cavernous lymphangioma in the part of the chin and neck. Case: 27 year-old woman who visited our hospital on September, 2007 to swelling in the neck and tongue. Tumor extraction (loss in quantity) was performed in March, 2009. Clinical diagnosis was cavernous lymphangioma. Two years after a first time operation, the tumor increased again and performed the tumor extraction (loss quantity). Four years after a first time operation, that markedly increased in size, and we resected tumor.
References
1) Reinhardt, M. A., et al.: Treatment of childhood lymphangiomas with interferon-alpha. J Pediatr Hematol Oncol. 19 : 232-236, 1997.
2) Swetman, G. L., Berk, D .R., Vasanawala, S. S., Feinstein, J. A., Lane, A. T., Bruckner, A. L. : Sildenafil for severe lymphatic malformations. N Engl J Med. 366(4) : 384-386, 2012.
